ArticleFrontiers in cardiovascular medicine2026
Linear accelerator-based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly patients: results from long-term follow-up.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stereotactic arrhythmia radioablation (STAR) is an innovative therapeutic approach for cardiac arrhythmias, particularly ventricular tachycardia. Regarding atrial fibrillation (AF), the only study evaluating the safety and feasibility of STAR (photon linear accelerator-based) in elderly patients was published in 2,023. In this brief communication, we reported the long-term follow-up of the enrolled patients. The current data demonstrate the feasibility of STAR in elderly patients with paroxysmal AF and its potential to improve quality of life. The treatment remains experimental, and more comprehensive safety data are necessary; furthermore, its efficacy will require further evaluation in a comparative study vs. catheter ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.